Dangerous Drugs Menu

Receive a Free
Legal Consultation

  • This field is for validation purposes and should be left unchanged.

Januvia, a once daily pill, helps diabetic people manage their blood sugar levels. It’s also called Sitagliptin and is most effective when combined with diet and exercise. Januvia is not prescribed to treat type 1 diabetes.

Recent reports of dangerous side effects associated with both Januvia and Byetta, another type 2 diabetes medication, have raised concerns as to whether these medications’ health advantages outweigh their disadvantages.

While taking Januvia and Byetta, some users have reported complications, including dangerous and sometimes life-threatening health conditions. Specifically, studies have linked Januvia and Byetta to an increase in growth of pancreatic cells that have a higher potential to become malignant. This increases a person’s risk of pancreatic cancer.

Other serious side effects associated with Januvia include:

  • Acute pancreatitis (swelling of the pancreas)
  • Severe allergic reactions (rash, hives, difficulty breathing, swelling)
  • Fever
  • Red, blistered, swollen or peeling skin
  • Lactic acidosis
  • Upper respiratory infection
  • Nausea
  • Vomiting
  • Abdominal pain

Januvia is also linked to the development of hemorrhagic pancreatitis, which involves both inflammation and bleeding of the pancreas, and necrotizing pancreatitis, which involves the inflamed pancreas gradually destroying itself. Both are potentially fatal conditions.


Between October 2008 and February 2009, the U.S. Food and Drug Administration (FDA) received approximately 88 reports from people diagnosed with acute pancreatitis that they believed were linked to Januvia. The FDA reviewed the reports and found that 21 percent of the cases occurred within the first 30 days of taking the medication. The FDA confirmed users’ reports and reported the association.

recent study conducted by researchers at the University of California found a link between Januvia and an increased rate of pre-cancerous changes in the pancreas of diabetic patients. This pancreatic cell growth can be damaging and has the potential to become malignant.

Named shareholder Jayne Conroy

Named shareholder Jayne Conroy

Simmons Hanly Conroy is currently investigating serious health complications and pancreas damage linked to the use of Januvia. If you or someone you love has developed pancreatic problems after taking Januvia, the manufacturer may have failed in its duty to alert consumers of risks associated with the drug.

Please contact the Januvia lawyers, led by named shareholders Paul Hanly and Jayne Conroy, at the firm today for more information. Our experienced Januvia attorneys will evaluate your case, answer your questions and help you understand your legal rights in regard to filing a Januvia lawsuit. Contact us today.

Client Testimonials

My mom had a catastrophic stroke as a result of taking a weight-loss product. The Simmons firm fought tirelessly to get her the best result possible. Thanks to them we can afford to get her the medical and therapeutic care she needs.

View More Testimonials

- Mario

178 queries. 0.675 seconds